A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study

Summary

This study will evaluate the efficacy and safety of ALKS 5461.

Timeline

Start

2014-05

Primary completion

2015-12

Completion

2015-12

Outcome

Missed primary endpoint

registry p = 0.109; Least squares mean difference -1.8 (95% CI -4.1 to 0.4) NCT02158533 ↗

registry p = 0.975; Least squares mean difference 0.0 (95% CI -2.3 to 2.3) NCT02158533 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ALKS 5461	Unknown	—	Other

Indications